Search Results 551-560 of 23384 for B cell lymphomas
... B-cell lymphoma 2 (BCL2) inhibitor. A Study of CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma. Jacksonville, Fla ...
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
... B-Cell Lymphomas. Am J Clin Pathol. 2020 Feb 8; 153 (3):353-359. View PubMed ... Diagnosis and treatment of diffuse large B-cell lymphoma in an orangutan (Pongo ...
They will investigate how IRF4 controls the interaction between lymphoma B cells and the immune cells called T cells. They will also explore how IRF4 ...
Anyone have chronic lymphocytic leukemia (CLL)?. 155 Replies Wed, Feb 25, 2026. georgie2 · Primary cutaneous marginal zone B-cell lymphoma (PCMZL). 30 Replies ...
Exploring the Role of B-cell Activating Factor ... lymphoma, chronic lymphocytic leukemia (CLL) and ... cells in autoimmune rheumatologic diseases ...
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...
Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma. La Crosse, Wis., Scottsdale/Phoenix, Ariz ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.